Your Source for Venture Capital and Private Equity Financings

Axonics Modulation Technologies Inks $32.6M in Series A

IRVINE, CA, Developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million in Series A.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors

Featured Reading